CCHR UK is committed to:
- Helping the media publicise medical atrocities
- Ensuring that the public are aware of workable treatments rather than dangerous drugs
- Influencing lawmakers to reduce exposure to dangerous drugs and dangerous practices
Please read and use freely the details given below and elsewhere on this web site. We have a wide selection of media and film that has been used in many documentaries and articles. Please also help us by completing the following form with your details and let us know how else we can assist you.
What the public are NOT being told
In 2010, there were 42.7 million prescriptions for antidepressant drugs dispensed in England. The cost to the NHS was £220.3 million. Research shows that a new generation of antidepressants have little clinical effect on the majority of depressed patients. Freedom of Information requests were used to uncover this information as it had not previously been released. A major study of post-menopausal problems found that those taking antidepressants were 45% more likely to suffer a stroke than those of the same age not on the drugs. The research also found that overall death rates were 32 per cent higher in women on the drugs.
Who protects our children?
Over 86,000 prescriptions for anti-psychotics – powerful tranquilliser drugs – were issued to children under 18 in 2007. This was at a cost of £3.5 million to the NHS. An in-depth analysis revealed that “children on anti-psychotic medication are more likely to die earlier”. Nobody knows how the drugs affect a growing child’s body or what may happen in the long term, yet they are still being prescribed to children under six years-old.
In September 2011, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug alert on antipsychotics prescribed to women during thier third trimester of pregnancy. The alert claimed the antipsychotics were causing newborn babies to suffer severe withdrawal symptoms and extrapyramidal symptoms [irreversable and involuntary movement disorders such as Akathisia, Tardive Dyskinesia and Parkinson’s Disease].
The medicalising of all human behaviour
The Diagnostic and Statistical Manual of Mental Disorders (DSM), is the mental health ‘bible’ which attempts to categorise every human emotion, experience, habit and activity. These are then listed as symptoms of ‘mental disorders’ such as ‘Hoarding disorder’ or ‘Binge eating disorder’.
The Third Edition of the DSM, published in 1968, included 182 disorders and was 134 pages long. The Fourth Edition published in 1994 included 297 disorders and was 886 pages long.
The size of the manual has increased, as has the volume of drugs used to ‘treat’ the so-called illnesses, along with the pharmaceutical company sales and profits.
The global market for prescription drugs was worth more than £72 billion in 2005 and over £76 billion in 2006.
In a 2006 report, the potential conflicts of interest of panel members responsible for modifying the diagnostic criteria for mental illness in the DSM was examined. It was found there are strong financial ties between the pharmaceutical industry and those members, particularly in those diagnostic areas where drugs are the first line of treatment for mental disorders.